# OnCo record nct05751512 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05751512/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05751512", "NCT05751512" ;
  schema:name "A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN"@en ;
  schema:description "A phase 3 trial testing MRG003 in head and neck squamous cell carcinoma, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05751512/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05751512> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-04-04" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:drugs <https://onco.cc/drugs/mrg003/> ;
  onco:companies <https://onco.cc/companies/lepu-biopharma/> .
